Compliance von Patienten mit altersabhängiger Makuladegeneration unter Anti-VEGF-Therapie-Reference-Cited by-同舟云学术

Compliance von Patienten mit altersabhängiger Makuladegeneration unter Anti-VEGF-Therapie

Published:2016-06-06 Issue:11 Volume:113 Page:925-932
ISSN:0941-293X
Container-title:Der Ophthalmologe
language:de
Short-container-title:Ophthalmologe

Author:

Heimes B.,Gunnemann F.,Ziegler M.,Gutfleisch M.,Spital G.,Pauleikhoff D.,Lommatzsch A.

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

http://link.springer.com/content/pdf/10.1007/s00347-016-0275-z.pdf

Reference20 articles.

1. Berg K, Pedersen TR, Sandvik L et al (2015) Comparison of Ranibizumab and Bevacizumab for Neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol. Ophthalmology 122:146–152

2. Brown DM, Kaiser PK, Michels M et al (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355:1432–1444

3. Catt Research Group (2011) Ranibizumab and Bevacizumab for Neovascular age-related macular degeneration. N Engl J Med 364(20):1897–1908. doi: 10.1056/NEJMoa1102673

4. Chakravarthy U, Harding SP, Rogers CA et al (2013) Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2‑year findings of the IVAN randomised controlled trial. Lancet 18:61501–61509

5. Chakravarthy U, Harding SP, Rogers CA et al (2012) Ranibizumab versus Bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial. Ophthalmology 119:1399–1411

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Home Optical Coherence Tomography Monitoring for Neovascular Age-Related Macular Degeneration: Transformative Technology or Cool Toy?;Ophthalmology and Therapy;2024-05-05

2. Anti-VEGF injection therapeutic methods for treatment of Age-related Macular Degeneration (AMD);2024-04-08

3. Towards a population pharmacokinetic/pharmacodynamic model of anti-VEGF therapy in patients with age-related macular degeneration;European Journal of Pharmaceutics and Biopharmaceutics;2023-07

4. Non-adherence and non-persistence to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy: a systematic review and meta-analysis;Systematic Reviews;2023-06-02

5. Long-term persistence with aflibercept therapy among treatment-naïve patients with exudative age-related macular degeneration in a universal health care system: a retrospective study;BMC Ophthalmology;2022-09-19